Showing results (111-120 of 170) with videos related to

Sort By:
Pageof 17
Cancers|March 13, 2025
Prognostic Frailty-Based Determinants of Long-Term Mortality in Older Patients with Newly Diagnosed Multiple MyelomaMariya Muzyka, Silvia Ottaviani, Irene Caffa, et al.
Autophagy|February 4, 2014
A critical role of autophagy in antileukemia/lymphoma effects of APO866, an inhibitor of NAD biosynthesisVanessa Ginet, Julien Puyal, Coralie Rummel, et al.
Internal and Emergency Medicine|August 2, 2024
Aromatase inhibitor-induced bone loss osteosarcopenia in older patients with breast cancer: effects of the RANK/RANKL system's inhibitor denosumab vs. bisphosphonatesAndrea Casabella, Francesca Paladin, Claudia Bighin, et al.
Neoplasia (New York, N.Y.)|May 6, 2023
Mitochondrial rewiring drives metabolic adaptation to NAD(H) shortage in triple negative breast cancer cellsAgata Sofia Assuncao Carreira, Silvia Ravera, Chiara Zucal, et al.
Blood|December 23, 2004
Evidence for a protective role of Mcl-1 in proteasome inhibitor-induced apoptosisAlessio Nencioni, Fei Hua, Christopher P Dillon, et al.
Thrombosis and Haemostasis|August 9, 2013
Treatment with the CC chemokine-binding protein Evasin-4 improves post-infarction myocardial injury and survival in miceVincent Braunersreuther, Fabrizio Montecucco, Graziano Pelli, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2016
Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitorsMauro Di Matteo, Alessandra Ammazzalorso, Federico Andreoli, et al.
Oncotarget|December 6, 2019
Reactive oxygen/nitrogen species contribute substantially to the antileukemia effect of APO866, a NAD lowering agentAnne-Julie Cloux, Dominique Aubry, Mathieu Heulot, et al.
Current Cancer Drug Targets|January 22, 2010
Ras-induced resistance to lapatinib is overcome by MEK inhibitionGabriele Zoppoli, Eva Moran, Debora Soncini, et al.
European Journal of Clinical Investigation|July 11, 2020
Comprehensive geriatric assessment in older adults with cancer: Recommendations by the Italian Society of Geriatrics and Gerontology (SIGG)Domenico Fusco, Alessandro Ferrini, Giuseppe Pasqualetti, et al.
Pageof 17